David Ovalle,

David Ovalle is a national reporter known for his work on opioids and addiction. He currently covers health and science for The Washington Post, where he focuses on topics such as opioids and addiction. Prior to joining The Washington Post, Ovalle worked at the Miami Herald, where he reported on crime, justice, and hurricanes. His articles often cover important public health issues and are well-researched and written in a clear manner.

71%

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

88%

Examples:

  • David Ovalle is a reporter for the Health & Science team who covers opioids and addiction. His previous work experience includes covering crime, justice, and hurricanes.
  • The bias in the article titled 'Princess Catherine’s diagnosis comes amid rise in some early-onset cancers' lies in the misleading statement that Princess Catherine's cancer diagnosis is rare while statistics show cancers are becoming more common among young people globally.

Conflicts of Interest

75%

Examples:

  • The article 'FDA approves self-collection screening for virus that causes cervical cancer' mentions the FDA approval of a self-collection screening test for HPV, which may lead readers to believe that the author has a conflict of interest related to the pharmaceutical industry.

Contradictions

100%

Examples:

No current examples available.

Deceptions

45%

Examples:

  • The article 'Princess Catherine’s diagnosis comes amid rise in some early-onset cancers' deceptively implies that Princess Catherine's cancer diagnosis is rare when it actually falls within the rising trend of cancers among young people.

Recent Articles

FDA Approves Self-Collection for Cervical Cancer Screening: Expanding Access and Convenience with HPV Tests by Roche and BD

FDA Approves Self-Collection for Cervical Cancer Screening: Expanding Access and Convenience with HPV Tests by Roche and BD

Broke On: Wednesday, 15 May 2024 The FDA's approval of self-collection for cervical cancer screening using HPV tests from Roche and BD marks a significant step towards expanding access and convenience. This decision, which could lead to home testing in the future, is expected to increase opportunities for early detection and treatment while reducing barriers for marginalized communities.
Younger Individuals at Increased Risk of Cancer: A Growing Concern in High-Income Countries

Younger Individuals at Increased Risk of Cancer: A Growing Concern in High-Income Countries

Broke On: Monday, 25 March 2024 Younger individuals are increasingly being diagnosed with cancer, particularly in high-income countries. While the overall mortality from cancer has dropped due to improved treatment and screening, researchers are still trying to understand why this trend is happening.